Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-FR
Language French French
Date Updated 2022-07-10 2022-06-09
Drug Identification Number 02417170 02417170
Brand name CONSTELLA CONSTELLA
Common or Proper name linaclotide capsules linaclotide capsules
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients LINACLOTIDE LINACLOTIDE
Strength(s) 290MCG 290MCG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30s 30s
ATC code A06AX A06AX
ATC description DRUGS FOR CONSTIPATION DRUGS FOR CONSTIPATION
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-06-09 2022-06-09
Actual start date
Estimated end date 2022-07-08 2022-07-08
Actual end date 2022-07-08
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments